Laura Niklason (Humacyte)

Pi­o­neer­ing re­gen­er­a­tive med sci­en­tist Lau­ra Nikla­son takes her com­pa­ny pub­lic in the lat­est big SPAC deal. And that gives her a shot at mak­ing biotech his­to­ry

Lau­ra Nikla­son left a promi­nent po­si­tion at Yale last fall so she could take charge of her re­gen­er­a­tive med biotech at a crit­i­cal point in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.